J. Hay

发表

Molecular and genetic aspects of lung cancer.

T. Lee, W. Rom, Y. Jiang, 2000, American journal of respiratory and critical care medicine.

Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: the importance of the adenoviral E1b-55kD gene.

W. Rom, J. Hay, N. Shapiro, 1999, Human gene therapy.

A novel cell-penetrating peptide to facilitate intercellular transport of fused proteins.

J. Hay, H. Sauthoff, Ying Shen, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Dysregulation of angiopoietin-1 plays a mechanistic role in the pathogenesis of cerebral malaria

L. Purcell, K. Kain, A. Conroy, 2016, Science Translational Medicine.

Angiopoietin-1 increases survival and reduces the development of lung edema induced by endotoxin administration in a murine model of acute lung injury

Jin Cheng, J. Hay, H. Sauthoff, 2008, Critical care medicine.

Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector.

W. Rom, J. Hay, H. Sauthoff, 2000, Human gene therapy.

Human matrix metalloproteinase-8 gene delivery increases the oncolytic activity of a replicating adenovirus.

W. Rom, Jin Cheng, J. Hay, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.

R. Crystal, C. Chu, J. Hay, 1994, The Journal of clinical investigation.

Human CC10 gene expression in airway epithelium and subchromosomal locus suggest linkage to airway disease.

R. Crystal, C. Chu, J. Hay, 1995, The American journal of physiology.

The potential impact of hypoxia on the success of oncolytic virotherapy.

J. Hay, 2005, Current opinion in molecular therapeutics.

A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung.

S. Brody, C. Chu, J. Hay, 1995, Human gene therapy.

Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved--deletion of the viral E1b-19-kD gene increases the viral oncolytic effect.

W. Rom, J. Jagirdar, J. Hay, 2001, Human gene therapy.

Gene therapy for the respiratory manifestations of cystic fibrosis.

S. Brody, C. Chu, N. Eissa, 1995, American journal of respiratory and critical care medicine.

Expressed cell-penetrating peptides can induce a bystander effect, but passage through the secretory pathway reduces protein transduction activity.

J. Hay, H. Sauthoff, Ying Shen, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis

R. Crystal, S. Brody, C. Chu, 1994, Nature Genetics.

Sindbis virus--an effective targeted cancer therapeutic.

J. Hay, 2004, Trends in biotechnology.

Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points.

W. Rom, H. Yee, J. Hay, 2003, Human gene therapy.

Modification of the p53 transgene of a replication-competent adenovirus prevents mdm2- and E1b-55kD-mediated degradation of p53

W. Rom, Jin Cheng, J. Hay, 2006, Cancer Gene Therapy.

Comparison of three different methods used to achieve local anesthesia for fiberoptic bronchoscopy.

J. Hay, J. Clague, J. Earis, 1993, Chest.

Comparison of Three Different Methods Used to Achieve Local Anesthesia for Fiberoptic Bronchoscopy

J. Hay, J. Clague, J. Earis, 1992 .

Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression

W. Rom, J. Hay, H. Sauthoff, 2005, Gene Therapy.

278. Hypoxia Reduces Adenoviral Replication in Cancer Cells by Down-Regulation of Viral Protein Expression

W. Rom, J. Hay, H. Sauthoff, 2004 .

Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein.

W. Rom, R. Norman, J. Hay, 2002, Human gene therapy.

Impact of E1a modifications on tumor-selective adenoviral replication and toxicity.

W. Rom, R. Norman, J. Hay, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Drug evaluation: Reolysin--wild-type reovirus as a cancer therapeutic.

J. Hay, J. Stoeckel, 2006, Current opinion in molecular therapeutics.

Vulnerability of the human airway epithelium to hyperoxia. Constitutive expression of the catalase gene in human bronchial epithelial cells despite oxidant stress.

R. Crystal, S. Erzurum, J. Hay, 1994, The Journal of clinical investigation.

Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector.

R. Crystal, J. Hay, N. McElvaney, 1995, Human gene therapy.

Hut Lung: A Domestically Acquired Particulate Lung Disease

W. Rom, D. Naidich, D. Addrizzo-Harris, 2000, Medicine.

Identification of a 27 bp 5'-flanking region element responsible for the low level constitutive expression of the human cytosolic phospholipase A2 gene.

R. Crystal, J. Hay, A. Miyashita, 1995, Nucleic acids research.

"Man's best friend": a new model system for cancer therapeutics?

J. Hay, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

New Drug for Sepsis on the Cheap?

J. Hay, H. Sauthoff, 2015, Critical Care Medicine.